Noriko Yoneda
University of Toyama
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Noriko Yoneda.
PLOS ONE | 2014
Arihiro Shiozaki; Satoshi Yoneda; Noriko Yoneda; Rika Yonezawa; Takamichi Matsubayashi; Genichiro Seo; Shigeru Saito
Preterm birth is a leading cause of perinatal morbidity and mortality. Studies using a cultivation method or molecular identification have shown that bacterial vaginosis is one of the risk factors for preterm birth. However, an association between preterm birth and intestinal microbiota has not been reported using molecular techniques, although the vaginal microbiota changes during pregnancy. Our aim here was to clarify the difference in intestinal and vaginal microbiota between women with preterm birth and women without preterm labor. 16S ribosomal ribonucleic acid genes were amplified from fecal and vaginal DNA by polymerase chain reaction. Using terminal restriction fragment length polymorphism (T-RFLP), we compared the levels of operational taxonomic units of both intestinal and vaginal flora among three groups: pregnant women who delivered term babies without preterm labor (non-PTL group) (n = 20), those who had preterm labor but delivered term babies (PTL group) (n = 11), and those who had preterm birth (PTB group) (n = 10). Significantly low levels of Clostridium subcluster XVIII, Clostridium cluster IV, Clostridium subcluster XIVa, and Bacteroides, and a significantly high level of Lactobacillales were observed in the intestinal microbiota in the PTB group compared with those in the non-PTL group. The levels of Clostridium subcluster XVIII and Clostridium subcluster XIVa in the PTB group were significantly lower than those in the PTL group, and these levels in the PTL group were significantly lower than those in non-PTL group. However, there were no significant differences in vaginal microbiota among the three groups. Intestinal microbiota in the PTB group was found to differ from that in the non-PTL group using the T-RFLP method.
American Journal of Reproductive Immunology | 2016
Noriko Yoneda; Satoshi Yoneda; Hideki Niimi; Tomohiro Ueno; Shirou Hayashi; Mika Ito; Arihiro Shiozaki; Daichi Urushiyama; Kenichiro Hata; Wataru Suda; Masahira Hattori; Mika Kigawa; Isao Kitajima; Shigeru Saito
To study the relationship between perinatal prognosis in cases of preterm labor (PTL) and polymicrobial infection in amniotic fluid (AF) and intra‐amniotic (IA) inflammation using a highly sensitive and reliable PCR‐based method.
Journal of Obstetrics and Gynaecology Research | 2011
Satoshi Yoneda; Arihiro Shiozaki; Noriko Yoneda; Tomoko Shima; Mika Ito; Mikiko Yamanaka; Takao Hidaka; Shigeki Sumi; Shigeru Saito
Aim: To examine whether delivery time for preterm labor can be predicted by clinical and biochemical markers at admission.
American Journal of Reproductive Immunology | 2015
Satoshi Yoneda; Arihiro Shiozaki; Mika Ito; Noriko Yoneda; Kumiko Inada; Rika Yonezawa; Mika Kigawa; Shigeru Saito
To estimate the stage of histological chorioamnionitis (h‐CAM) antenatally using clinical data.
PLOS ONE | 2015
Tomohiro Ueno; Hideki Niimi; Noriko Yoneda; Satoshi Yoneda; Masashi Mori; Homare Tabata; Hiroshi Minami; Shigeru Saito; Isao Kitajima
Background Intra-amniotic infection has long been recognized as the leading cause of preterm delivery. Microbial culture is the gold standard for the detection of intra-amniotic infection, but several days are required, and many bacterial species in the amniotic fluid are difficult to cultivate. Methods We developed a novel nested-PCR-based assay for detecting Mycoplasma, Ureaplasma, other bacteria and fungi in amniotic fluid samples within three hours of sample collection. To detect prokaryotes, eukaryote-made thermostable DNA polymerase, which is free from bacterial DNA contamination, is used in combination with bacterial universal primers. In contrast, to detect eukaryotes, conventional bacterially-made thermostable DNA polymerase is used in combination with fungal universal primers. To assess the validity of the PCR assay, we compared the PCR and conventional culture results using 300 amniotic fluid samples. Results Based on the detection level (positive and negative), 93.3% (280/300) of Mycoplasma, 94.3% (283/300) of Ureaplasma, 89.3% (268/300) of other bacteria and 99.7% (299/300) of fungi matched the culture results. Meanwhile, concerning the detection of bacteria other than Mycoplasma and Ureaplasma, 228 samples were negative according to the PCR method, 98.2% (224/228) of which were also negative based on the culture method. Employing the devised primer sets, mixed amniotic fluid infections of Mycoplasma, Ureaplasma and/or other bacteria could be clearly distinguished. In addition, we also attempted to compare the relative abundance in 28 amniotic fluid samples with mixed infection, and judged dominance by comparing the Ct values of quantitative real-time PCR. Conclusions We developed a novel PCR assay for the rapid detection of Mycoplasma, Ureaplasma, other bacteria and fungi in amniotic fluid samples. This assay can also be applied to accurately diagnose the absence of bacteria in samples. We believe that this assay will positively contribute to the treatment of intra-amniotic infection and the prevention of preterm delivery.
American Journal of Reproductive Immunology | 2016
Satoshi Yoneda; Arihiro Shiozaki; Noriko Yoneda; Mika Ito; Tomoko Shima; Kaori Fukuda; Tomohiro Ueno; Hideki Niimi; Isao Kitajima; Mika Kigawa; Shigeru Saito
To examine the efficacy of the use of antibiotics in preterm labor (PTL) with intact membranes, after evaluating intra‐amniotic microbes by our rapid and bacteria‐free polymerase chain reaction (PCR) system.
Cell Transplantation | 2013
Zan Teng; Toshiko Yoshida; Motonori Okabe; Ayaka Toda; Osamu Higuchi; Makiko Nogami; Noriko Yoneda; Kaixuan Zhou; Satoru Kyo; Touru Kiyono; Toshio Nikaido
Human amniotic mesenchymal cells (HAM cells) are known to contain somatic stem cells possessing the characteristics of pluripotency. However, little is known about the biology of these somatic cells because isolated HAM cells from amniotic membrane have a limited lifespan. To overcome this problem, we attempted to prolong the lifespan of HAM cells by infecting retrovirus encoding human papillomavirus type16E6 and E7 (HPV16E6E7), bmi-1, and/or human telomerase reverse transcriptase (hTERT) genes and investigated their characteristics as stem cells. We confirmed the immortalization of the four lines of cultured HAM cells for about 1 year. Immortalized human amnion mesenchymal cells (iHAM cells) have continued to proliferate over 200 population doublings (PDs). iHAM cells were positive for CD73, CD90, CD105, and CD44 and negative for CD34, CD14, CD45, and HLA-DR. They expressed stem cell markers such as Oct3/4, Sox2, Nanog, Klf4, SSEA4, c-myc, vimentin, and nestin. They showed adipogenic, osteogenic, and chondrogenic differentiation abilities after induction. These results suggested that immortalized cell lines with characteristics of stem cells can be established. iHAM cells with an extended lifespan can be used to produce good experimental models both in vitro and in vivo.
Placenta | 2013
Noriko Yoneda; Arihiro Shiozaki; Kiyonori Miura; Rika Yonezawa; K. Takemura; Satoshi Yoneda; H. Masuzaki; Shigeru Saito
Partial hydatidiform mole with a normal fetus is extremely rare. A 30-year-old woman presented at 19 weeks gestation with clinical manifestations of severe preeclampsia. The fetus revealed a normal 46,XX karyotype and the placenta revealed triploid 69,XXX from paternal isodisomy. Microsatellite analysis revealed that the fetus and the triploid partial mole were derived from one sperm and one oocyte, followed by duplication of paternal chromosomes in only a trophectodermal cell. The maternal serum levels of angiogenic factors were extremely high compared with those reported in preeclampsia, suggesting an angiogenic imbalance may have caused preeclampsia-like symptoms before 20 weeks of gestation.
Journal of Obstetrics and Gynaecology Research | 2011
Toru Hasegawa; Yoko Ishii; Rika Yonezawa; Noriko Yoneda; Tomoko Shima; Akitoshi Nakashima; Takao Hidaka; Shigeru Saito
Since ovarian cancer during pregnancy is rare, the decisions regarding pregnancy discontinuation or fertility preservation are often difficult. We report three ovarian cancer cases detected at early, mid and late pregnancy periods in which both babies and mothers were saved. In particular, case 2 is the first reported instance of a sertoliform endometrioid carcinoma of the ovary during pregnancy. In addition, we review the clinical characteristics of previously reported patients with stage I ovarian cancer diagnosed during pregnancy.
Journal of Obstetrics and Gynaecology Research | 2011
Aiko Aoki; Noriko Yoneda; Satoshi Yoneda; Takayoshi Miyazono; Toshiro Sugiyama; Shigeru Saito
A pregnant woman was diagnosed with acute promyelocytic leukemia at 38 weeks of gestation. Induction of labor was successful, and the patient delivered a healthy male baby. Soon after delivery, she was treated with chemotherapy using all‐trans‐retinoic acid (ATRA). The number of white blood cells was increased on the fifth postpartum day and retinoic acid syndrome (RAS) was considered a concern. On the sixth postpartum day, remission induction chemotherapy with idarubicin and cytosine arabinoside was started. On the seventh postpartum day, massive uterine bleeding of more than 1300 mL suddenly occurred. As administration of cytotoxic agents may induce disseminated intravascular coagulation, we should take care to avoid uterine bleeding after chemotherapy in acute promyelocytic leukemia cases treated soon after delivery.